Charles Schwab Investment Management Inc Precigen, Inc. Transaction History

Charles Schwab Investment Management Inc

$521 Billion
Q1 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Precigen, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,216,764 shares of PGEN stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,216,764

Previous 1,278,862 4.86%

Holding current value

$1.61 Million

Previous $1.43 Million 26.54%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$1.07 - $2.03 $66,444 - $126,058	-62,098 Reduced 4.86%	1,216,764 $1.81 Million
Q4 2024 Feb 06, 2025	BUY	$0.67 - $1.12 $37,528 - $62,733	56,012 Added 4.58%	1,278,862 $1.43 Million
Q3 2024 Nov 12, 2024	BUY	$0.91 - $1.88 $115,994 - $239,637	127,467 Added 11.64%	1,222,850 $1.16 Million
Q2 2024 Aug 12, 2024	BUY	$1.27 - $1.75 $34,107 - $46,998	26,856 Added 2.51%	1,095,383 $1.73 Million
Q1 2024 May 08, 2024	BUY	$1.21 - $1.75 $71,521 - $103,440	59,109 Added 5.86%	1,068,527 $1.55 Million
Q4 2023 Feb 06, 2024	SELL	$0.89 - $1.41 $45,480 - $72,053	-51,102 Reduced 4.82%	1,009,418 $1.35 Million
Q3 2023 Nov 08, 2023	SELL	$1.08 - $1.85 $40,131 - $68,744	-37,159 Reduced 3.39%	1,060,520 $1.51 Million
Q2 2023 Aug 09, 2023	BUY	$0.96 - $1.4 $60,557 - $88,313	63,081 Added 6.1%	1,097,679 $1.26 Million
Q1 2023 May 11, 2023	BUY	$0.88 - $2.19 $243,906 - $606,993	277,166 Added 36.59%	1,034,598 $1.1 Million
Q4 2022 Feb 13, 2023	BUY	$1.27 - $2.26 $13,851 - $24,649	10,907 Added 1.46%	757,432 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$1.41 - $2.79 $109,558 - $216,785	77,701 Added 11.62%	746,525 $1.58 Million
Q2 2022 Aug 15, 2022	SELL	$1.15 - $2.53 $62,461 - $137,414	-54,314 Reduced 7.51%	668,824 $897,000
Q1 2022 May 13, 2022	SELL	$1.91 - $3.98 $58,382 - $121,656	-30,567 Reduced 4.06%	723,138 $1.53 Million
Q4 2021 Feb 11, 2022	BUY	$3.53 - $5.5 $54,224 - $84,485	15,361 Added 2.08%	753,705 $2.8 Million
Q3 2021 Nov 16, 2021	BUY	$4.99 - $6.55 $61,945 - $81,311	12,414 Added 1.71%	738,344 $3.69 Million
Q2 2021 Aug 16, 2021	BUY	$6.24 - $8.22 $889,742 - $1.17 Million	142,587 Added 24.44%	725,930 $4.73 Million
Q1 2021 May 17, 2021	BUY	$6.74 - $10.95 $781,381 - $1.27 Million	115,932 Added 24.8%	583,343 $4.02 Million
Q4 2020 Feb 16, 2021	BUY	$3.75 - $10.56 $54,513 - $153,510	14,537 Added 3.21%	467,411 $4.77 Million
Q3 2020 Nov 13, 2020	BUY	$3.5 - $6.2 $2,628 - $4,656	751 Added 0.17%	452,874 $1.59 Million
Q2 2020 Aug 14, 2020	BUY	$2.16 - $5.46 $10,672 - $26,977	4,941 Added 1.1%	452,123 $2.26 Million
Q1 2020 May 15, 2020	BUY	$1.46 - $7.19 $652,885 - $3.22 Million	447,182 New	447,182 $1.52 Million

Others Institutions Holding PGEN

# of Institutions

153

Shares Held

164M

Call Options Held

1.11M

Put Options Held

36.8K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $275M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Precigen, Inc. Transaction History